Advanced search
Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 36, 2024 - Issue 5
Submit an article Journal homepage
203
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Alcohol and drug use severity are independently associated with antiretroviral adherence in the current treatment era

J. Maa Department of Medicine, University of Washington, Seattle, WA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6849-3206View further author information
ORCID Icon,
B. Luub Department of Medicine, University of Toronto, Toronto, CanadaView further author information
,
S. A. Rudermana Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
B. M. Whitneya Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
J. O. Merrilla Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
L. S. Mixsona Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
R. M. Nancea Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
L. N. Drumrighta Department of Medicine, University of Washington, Seattle, WA, USA;c Department of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, WA, USAView further author information
,
A. W. Hahna Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
R. J. Fredericksena Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
G. Chandera Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
B. Laud Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USAView further author information
,
M. E. McCaule Department of Psychiatry, Johns Hopkins University, Baltimore, MD, USAView further author information
,
S. Safrenf Department of Psychology, University of Miami, Miami, FL, USAORCID Iconhttps://orcid.org/0000-0002-0121-0806View further author information
ORCID Icon,
C. O'Cleirighg Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA;h Department of Psychology, Harvard Medical School, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0002-5639-5043View further author information
ORCID Icon,
K. Cropseyi Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
K. H. Mayerj Department of Medicine, Harvard Medical School, Boston, MA, USA;k The Fenway Institute, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-7460-733XView further author information
ORCID Icon,
W. C. Mathewsl Department of Medicine, University of California, San Diego, CA, USAView further author information
,
R. D. Moorem Department of Medicine, Johns Hopkins University, Baltimore, MD, USAView further author information
,
S. Napravnikn Department of Medicine, University of North Carolina, Chapel Hill, NC, USA;o Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USAView further author information
,
K. Christopoulosp Department of Medicine, University of California, San Francisco, CA, USAView further author information
,
A. Willigi Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
J. M. Jacobsonq Department of Medicine, Case Western Reserve University, Cleveland, OH, USAView further author information
,
A. Webelr Department of Child, Family, and Population Health Nursing, Unviersity of Washington, Seattle, WA, USAView further author information
,
G. Burkholderi Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
M. J. Mugaveroi Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
M. S. Saagi Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAView further author information
,
M. M. Kitahataa Department of Medicine, University of Washington, Seattle, WA, USAView further author information
,
H. M. Cranea Department of Medicine, University of Washington, Seattle, WA, USAView further author information
&
J. A. C. Delaneya Department of Medicine, University of Washington, Seattle, WA, USA;s College of Pharmacy, University of Manitoba, Winnipeg, CanadaView further author information
 show all
Pages 618-630 | Received 13 Sep 2021, Accepted 05 Jun 2023, Published online: 07 Jul 2023

References

  • Adebajo, S., Obianwu, O., Eluwa, G., Vu, L., Oginni, A., Tun, W., Sheehy, M., Ahonsi, B., Bashorun, A., & Idogho, O. (2014). Comparison of audio computer assisted self-interview and face-to-face interview methods in eliciting HIV-related risks among men who have sex with men and men who inject drugs in Nigeria. PloS One, 9(1), e81981. https://doi.org/10.1371/journal.pone.0081981
  • Altice, F., Evuarherhe, O., Shina, S., Carter, G., & Beaubrun, A. C. (2019). Adherence to HIV treatment regimens: Systematic literature review and meta-analysis. Patient Preference and Adherence, 13, 475–490. https://doi.org/10.2147/PPA.S192735
  • Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367–387. https://doi.org/10.1016/S0140-6736(10)60829-X
  • Amico, K. R., Fisher, W. A., Cornman, D. H., Shuper, P. A., Redding, C. G., Konkle-Parker, D. J., Barta, W., & Fisher, J. D. (2006). Visual analog scale of ART adherence: Association with 3-day self-report and adherence barriers. Journal of Acquired Immune Deficiency Syndromes (1999), 42(4), 455–459. https://doi.org/10.1097/01.qai.0000225020.73760.c2
  • Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417–1423. https://doi.org/10.1086/323201
  • Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug And Alcohol Dependence, 112(3), 178–193. https://doi.org/10.1016/j.drugalcdep.2010.06.014
  • Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (London, England), 15(9), 1181–1183. https://doi.org/10.1097/00002030-200106150-00015
  • Batchelder, A. W., Safren, S., Mitchell, A. D., Ivardic, I., & O’Cleirigh, C. (2017). Mental health in 2020 for men who have sex with men in the United States. Sexual Health, 14(1), 59–71. https://doi.org/10.1071/SH16083
  • Bezabhe, W. M., Chalmers, L., Bereznicki, L. R., & Peterson, G. M. (2016). Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine, 95(15), e3361. https://doi.org/10.1097/MD.0000000000003361
  • Bonn-Miller, M. O., Oser, M. L., Bucossi, M. M., & Trafton, J. A. (2014). Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. Journal of Behavioral Medicine, 37(1), 1–10. https://doi.org/10.1007/s10865-012-9458-5
  • Bradley, K. A., Bush, K. R., Epler, A. J., Dobie, D. J., Davis, T. M., Sporleder, J. L., Maynard, C., Burman, M. L., & Kivlahan, D. R. (2003). Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): Validation in a female Veterans Affairs patient population. Archives of Internal Medicine, 163(7), 821–829. https://doi.org/10.1001/archinte.163.7.821
  • Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine, 158(16), 1789–1795. https://doi.org/10.1001/archinte.158.16.1789
  • Byrd, K. K., Hou, J. G., Hazen, R., Kirkham, H., Suzuki, S., Clay, P. G., Bush, T., Camp, N. M., Weidle, P. J., & Delpino, A. (2019). Antiretroviral adherence level necessary for HIV viral suppression using real-world data. Journal of Acquired Immune Deficiency Syndromes (1999), 82(3), 245–251. https://doi.org/10.1097/QAI.0000000000002142
  • Chander, G., Lau, B., & Moore, R. D. (2006). Hazardous alcohol use—A risk factor for non-adherence and lack of suppression in HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 43(4), 411–417. https://doi.org/10.1097/01.qai.0000243121.44659.a4
  • Chitsaz, E., Meyer, J. P., Krishnan, A., Springer, S. A., Marcus, R., Zaller, N., Jordan, A. O., Lincoln, T., Flanigan, T. P., Porterfield, J., & Altice, F. L. (2013). Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS and Behavior, 17(S2), 118–127. https://doi.org/10.1007/s10461-013-0506-0
  • Cohn, S. E., Jiang, H., McCutchan, J. A., Koletar, S. L., Murphy, R. L., Robertson, K. R., de St Maurice, A. M., Currier, J. S., & Williams, P. L. (2011). Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362. AIDS Care, 23(6), 775–785. https://doi.org/10.1080/09540121.2010.525617
  • Conen, A., Fehr, J., Glass, T. R., Furrer, H., Weber, R., Vernazza, P., Hirschel, B., Cavassini, M., Bernasconi, E., Bucher, H. C., & Battegay, M. (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral Therapy, 14(3), 349–357. https://doi.org/10.1177/135965350901400303
  • Crane, H. M., Lober, W., Webster, E., Harrington, R. D., Crane, P. K., Davis, T. E., & Kitahata, M. M. (2007). Routine collection of patient-reported outcomes in an HIV clinic setting: The first 100 patients. Current HIV Research, 5(1), 109–118. https://doi.org/10.2174/157016207779316369
  • Crane, H. M., McCaul, M. E., Chander, G., Hutton, H., Nance, R. M., Delaney, J. A. C., Merrill, J. O., Lau, B., Mayer, K. H., Mugavero, M. J., Mimiaga, M., Willig, J. H., Burkholder, G. A., Drozd, D. R., Fredericksen, R. J., Cropsey, K., Moore, R. D., Simoni, J. M., Christopher Mathews, W., … Kitahata, M. M. (2017). Prevalence and factors associated with hazardous alcohol use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS and Behavior, 21(7), 1914–1925. https://doi.org/10.1007/s10461-017-1740-7
  • Crane, P. K., Gibbons, L. E., Willig, J. H., Mugavero, M. J., Lawrence, S. T., Schumacher, J. E., Saag, M. S., Kitahata, M. M., & Crane, H. M. (2010). Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9). AIDS Care, 22(7), 874–885. https://doi.org/10.1080/09540120903483034
  • Delaney, J. A., Nance, R. M., Whitney, B. M., Altice, F. L., Dong, X., Trejo, M. E. P., Matsuzaki, M., Taxman, F. S., Chander, G., Kuo, I., Fredericksen, R., Strand, L. N., Eron, J. J., Geng, E., Kitahata, M. M., Mathews, W. C., Mayer, K., Moore, R. D., Saag, M. S., … Crane, H. M. (2018). Brief report: Reduced use of illicit substances, even without abstinence, is associated with improved depressive symptoms among people living with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes (1999), 79(3), 283–287. https://doi.org/10.1097/QAI.0000000000001803
  • Donnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., McIntyre, J., Lingappa, J. R., & Celum, C. (2010). Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. The Lancet, 375(9731), 2092–2098. https://doi.org/10.1016/S0140-6736(10)60705-2
  • Ford, N., Darder, M., Spelman, T., Maclean, E., Mills, E., & Boulle, A. (2010). Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: Five-year follow up of an observational cohort. PloS One, 5(5), e10460. https://doi.org/10.1371/journal.pone.0010460
  • Fredericksen, R., Crane, P. K., Tufano, J., Ralston, J., Schmidt, S., Brown, T., Layman, D., Harrington, R. D., Dhanireddy, S., Stone, T., Lober, W., Kitahata, M. M., & Crane, H. M. (2012). Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults. Journal of AIDS and HIV Research, 4(2), 47–55. https://doi.org/10.5897/jahr11.046
  • Glass, T. R., Sterne, J. A. C., Schneider, M.-P., De Geest, S., Nicca, D., Furrer, H., Günthard, H. F., Bernasconi, E., Calmy, A., Rickenbach, M., Battegay, M., & Bucher, H. C. (2015). Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. Aids (london, England), 29(16), 2195–2200. https://doi.org/10.1097/QAD.0000000000000782
  • Glick, S. N., Burt, R., Kummer, K., Tinsley, J., Banta-Green, C. J., & Golden, M. R. (2018). Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug and Alcohol Dependence, 182, 86–92. https://doi.org/10.1016/j.drugalcdep.2017.10.011
  • Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011). Substance use: Impact on adherence and HIV medical treatment. Current HIV/AIDS Reports, 8(4), 223–234. https://doi.org/10.1007/s11904-011-0093-5
  • Gonzalez, A., Mimiaga, M. J., Israel, J., Andres Bedoya, C., & Safren, S. A. (2013). Substance use predictors of poor medication adherence: The role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS and Behavior, 17(1), 168–173. https://doi.org/10.1007/s10461-012-0319-6
  • Gribble, J. N., Miller, H. G., Cooley, P. C., Catania, J. A., Pollack, L., & Turner, C. F. (2000). The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Substance Use & Misuse, 35(6-8), 869–890. https://doi.org/10.3109/10826080009148425
  • Gual, A., Segura, L., Contel, M., Heather, N., & Colom, J. (2002). Audit-3 and audit-4: Effectiveness of two short forms of the alcohol use disorders identification test. Alcohol and Alcoholism, 37(6), 591–596. https://doi.org/10.1093/alcalc/37.6.591
  • Haldane, V., Cervero-Liceras, F., Chuah, F. L. H., Ong, S. E., Murphy, G., Sigfrid, L., Watt, N., Balabanova, D., Hogarth, S., Maimaris, W., Buse, K., Piot, P., McKee, M., Perel, P., & Legido-Quigley, H. (2017). Integrating HIV and substance use services: A systematic review. Journal of the International AIDS Society, 20(1), 21585. https://doi.org/10.7448/IAS.20.1.21585
  • Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes (1999), 52(2), 180–202. https://doi.org/10.1097/QAI.0b013e3181b18b6e
  • Iacob, S. A., Iacob, D. G., & Jugulete, G. (2017). Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment—clinical points of view and practical considerations. Frontiers in Pharmacology, 8, 831. https://doi.org/10.3389/fphar.2017.00831
  • Jin, H., Ogunbajo, A., Mimiaga, M. J., Duncan, D. T., Boyer, E., Chai, P., Dilworth, S. E., & Carrico, A. W. (2018). Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men. Drug and Alcohol Dependence, 192, 125–128. https://doi.org/10.1016/j.drugalcdep.2018.07.038
  • Jones, C. M., Compton, W. M., & Mustaquim, D. (2020). Patterns and characteristics of methamphetamine use among adults — United States, 2015–2018. MMWR. Morbidity and Mortality Weekly Report, 69(12), 317–323. https://doi.org/10.15585/mmwr.mm6912a1
  • Kalichman, S. C., Grebler, T., Amaral, C. M., McNerey, M., White, D., Kalichman, M. O., Cherry, C., & Eaton, L. (2013). Intentional Non-adherence to medications among HIV positive alcohol drinkers: Prospective study of interactive toxicity beliefs. Journal of General Internal Medicine, 28(3), 399–405. https://doi.org/10.1007/s11606-012-2231-1
  • Kitahata, M. M., Rodriguez, B., Haubrich, R., Boswell, S., Mathews, W. C., Lederman, M. M., Lober, W. B., Van Rompaey, S. E., Crane, H. M., Moore, R. D., Bertram, M., Kahn, J. O., & Saag, M. S. (2008). Cohort profile: The centers for AIDS research network of integrated clinical systems. International Journal of Epidemiology, 37(5), 948–955. https://doi.org/10.1093/ije/dym231
  • Kozak, M. S., Mugavero, M. J., Ye, J., Aban, I., Lawrence, S. T., Nevin, C. R., Raper, J. L., McCullumsmith, C., Schumacher, J. E., Crane, H. M., Kitahata, M. M., Saag, M. S., & Willig, J. H. (2012). Patient reported outcomes in routine care: Advancing data capture for HIV cohort research. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 54(1), 141–147. https://doi.org/10.1093/cid/cir727
  • Lai, H.-H., Kuo, Y.-C., Kuo, C.-J., Lai, Y.-J., Chen, M., Chen, Y.-T., Chen, C.-C., Yen, M.-Y., Hu, B.-S., Wang, T.-H., Wang, C. C., Kuo, L.-L., Yen, T.-F., Chuang, P.-H., & Yen, Y.-F. (2020). Methamphetamine use associated with non-adherence to antiretroviral treatment in men who have sex with men. Scientific Reports, 10(1), 7131. https://doi.org/10.1038/s41598-020-64069-2
  • Lucas, G. M. (2011). Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. Life Sciences, 88(21-22), 948–952. https://doi.org/10.1016/j.lfs.2010.09.025
  • Macalino, G. E., Celentano, D. D., Latkin, C., Strathdee, S. A., & Vlahov, D. (2002). Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention, 14(5), 367–378. https://doi.org/10.1521/aeap.14.6.367.24075
  • Maloney, K. M., Beer, L., Tie, Y., & Dasgupta, S. (2020). Prevalence of non-medical amphetamine use among men with diagnosed HIV infection who have sex with men in the United States, 2015-2016. AIDS and Behavior, 24(6), 1865–1875. https://doi.org/10.1007/s10461-019-02761-9
  • Markowitz, M., & Grobler, J. A. (2020). Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1. Current Opinion in HIV and AIDS, 15(1), 27–32. https://doi.org/10.1097/COH.0000000000000599
  • Mayer, K. H., Nelson, L., Hightow-Weidman, L., Mimiaga, M. J., Mena, L., Reisner, S., Daskalakis, D., Safren, S. A., Beyrer, C., & Sullivan, P. S. (2021). The persistent and evolving HIV epidemic in American men who have sex with men. The Lancet, 397(10279), 1116–1126. https://doi.org/10.1016/S0140-6736(21)00321-4
  • Moatti, J. P., Carrieri, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., & Moreau, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. Aids (london, England), 14(2), 151–155. https://doi.org/10.1097/00002030-200001280-00010
  • Montgomery, L., Bagot, K., Brown, J. L., & Haeny, A. M. (2019). The association between marijuana use and HIV continuum of care outcomes: A systematic review. Current HIV/AIDS Reports, 16(1), 17–28. https://doi.org/10.1007/s11904-019-00422-z
  • Nance, R. M., Trejo, M. E. P., Whitney, B. M., Delaney, J. A. C., Altice, F. L., Beckwith, C. G., Chander, G., Chandler, R., Christopoulous, K., Cunningham, C., Cunningham, W. E., Del Rio, C., Donovan, D., Eron, J. J., Fredericksen, R. J., Kahana, S., Kitahata, M. M., Kronmal, R., Kuo, I., … Crane, H. M. (2020). Impact of abstinence and of reducing illicit drug Use without abstinence on human immunodeficiency virus viral load. Clinical Infectious Diseases, 70(5), 867–874. https://doi.org/10.1093/cid/ciz299
  • Newcombe, D. A., Humeniuk, R. E., & Ali, R. (2005). Validation of the world health organization alcohol, smoking and substance involvement screening test (ASSIST): report of results from the Australian site. Drug and Alcohol Review, 24(3), 217–226. https://doi.org/10.1080/09595230500170266
  • NIDA. (2021, April 13). Sex and gender differences in substance use. Sex and gender differences in substance use. https://nida.nih.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use.
  • Palamar, J. J., Han, B. H., & Keyes, K. M. (2020). Trends in characteristics of individuals who use methamphetamine in the United States, 2015-2018. Drug and Alcohol Dependence, 213, 108089. https://doi.org/10.1016/j.drugalcdep.2020.108089
  • Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction, 99(3), 361–368. https://doi.org/10.1111/j.1360-0443.2003.00670.x
  • Parsons, J. T., John, S. A., Millar, B. M., & Starks, T. J. (2018). Testing the efficacy of combined motivational interviewing and cognitive behavioral skills training to reduce methamphetamine use and improve HIV medication adherence among HIV-positive gay and bisexual men. AIDS and Behavior, 22(8), 2674–2686. https://doi.org/10.1007/s10461-018-2086-5
  • Parsons, J. T., Kowalczyk, W. J., Botsko, M., Tomassilli, J., & Golub, S. A. (2013). Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS and Behavior, 17(4), 1478–1487. https://doi.org/10.1007/s10461-013-0463-7
  • Paschen-Wolff, M. M., Campbell, A. N. C., Tross, S., Choo, T.-H., Pavlicova, M., & Jarlais, D. D. (2020). DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence. AIDS Care, 32(5), 645–650. https://doi.org/10.1080/09540121.2019.1686600
  • Rajasingham, R., Mimiaga, M. J., White, J. M., Pinkston, M. M., Baden, R. P., & Mitty, J. A. (2011). A systematic review of behavioral and treatment outcome studies among HIV-infected men who have Sex with men who abuse crystal methamphetamine. AIDS Patient Care and STDs, 26(1), 36–52. https://doi.org/10.1089/apc.2011.0153
  • Reback, C. J., Larkins, S., & Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775–785. https://doi.org/10.1080/09540120310001618621
  • Rosen, M. I., Black, A. C., Arnsten, J. H., Goggin, K., Remien, R. H., Simoni, J. M., Golin, C. E., Bangsberg, D. R., & Liu, H. (2013). Association between use of specific drugs and antiretroviral adherence: Findings from MACH 14. AIDS and Behavior, 17(1), 142–147. https://doi.org/10.1007/s10461-011-0124-7
  • Roux, P., Carrieri, M. P., Cohen, J., Ravaux, I., Poizot-Martin, I., Dellamonica, P., & Spire, B. (2009). Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49(9), 1433–1440. https://doi.org/10.1086/630209
  • Safren, S. A., O’Cleirigh, C., Skeer, M. R., Driskell, J., Goshe, B. M., Covahey, C., & Mayer, K. H. (2011). Demonstration and evaluation of a peer-delivered, individually-tailored, HIV prevention intervention for HIV-infected MSM in their primary care setting. AIDS and Behavior, 15(5), 949–958. https://doi.org/10.1007/s10461-010-9807-8
  • Safren, S. A., O’Cleirigh, C. M., Skeer, M., Elsesser, S. A., & Mayer, K. H. (2013). Project enhance: A randomized controlled trial of an individualized HIV prevention intervention for HIV-infected men who have sex with men conducted in a primary care setting. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 32(2), 171–179. https://doi.org/10.1037/a0028581
  • Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism: Clinical & Experimental Research, 28(4), 572–577. https://doi.org/10.1097/01.ALC.0000122103.74491.78
  • Segal-Maurer, S., DeJesus, E., Stellbrink, H. J., Castagna, A., Richmond, G. J., Sinclair, G. I., Siripassorn, K., Ruane, P. J., Berhe, M., Wang, H., Margot, N. A., Dvory-Sobol, H., Hyland, R. H., Brainard, D. M., Rhee, M. S., Baeten, J. M., Molina, J. M., & CAPELLA Study Investigators (2022). Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection. The New England Journal of Medicine, 386(19), 1793–1803. https://doi.org/10.1056/NEJMoa2115542
  • Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10(3), 227–245. https://doi.org/10.1007/s10461-006-9078-6
  • Socias, M. E., & Milloy, M.-J. (2018). Substance use and adherence to antiretroviral therapy: What is known and what is unknown. Current Infectious Disease Reports, 20(9), 36. https://doi.org/10.1007/s11908-018-0636-7
  • Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.
  • Sutton, S. S., Magagnoli, J., & Hardin, J. W. (2017). Odds of viral suppression by single-tablet regimens, multiple-tablet regimens, and adherence level in HIV/AIDS patients receiving antiretroviral therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37(2), 204–213. https://doi.org/10.1002/phar.1889
  • Swindells, S., Andrade-Villanueva, J.-F., Richmond, G. J., Rizzardini, G., Baumgarten, A., Masiá, M., Latiff, G., Pokrovsky, V., Bredeek, F., Smith, G., Cahn, P., Kim, Y.-S., Ford, S. L., Talarico, C. L., Patel, P., Chounta, V., Crauwels, H., Parys, W., Vanveggel, S., … Spreen, W. R. (2020). Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression. The New England Journal of Medicine, 382(12), 1112–1123. https://doi.org/10.1056/NEJMoa1904398
  • Thornhill, J., & Orkin, C. (2021). Long-acting injectable HIV therapies: The next frontier. Current Opinion in Infectious Diseases, 34(1), 8–15. https://doi.org/10.1097/QCO.0000000000000701
  • Tsui, J. I., Mayfield, J., Speaker, E. C., Yakup, S., Ries, R., Funai, H., Leroux, B. G., & Merrill, J. O. (2020). Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. Journal of Substance Abuse Treatment, 109, 80–85. https://doi.org/10.1016/j.jsat.2019.10.005
  • Viswanathan, S., Detels, R., Mehta, S. H., Macatangay, B. J. C., Kirk, G. D., & Jacobson, L. P. (2015). Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART). AIDS and Behavior, 19(4), 601–611. https://doi.org/10.1007/s10461-014-0927-4
  • Weber, R., Huber, M., Rickenbach, M., Furrer, H., Elzi, L., Hirschel, B., Cavassini, M., Bernasconi, E., Schmid, P., Ledergerber, B., & Study, the S. H. I. V. C. (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: The Swiss HIV Cohort Study. HIV Medicine, 10(7), 407–416. https://doi.org/10.1111/j.1468-1293.2009.00701.x
  • Weld, E. D., & Flexner, C. (2020). Long-acting implants to treat and prevent HIV infection. Current Opinion in HIV and AIDS, 15(1), 33–41. https://doi.org/10.1097/COH.0000000000000591
  • WHO ASSIST Working Group. (2002). The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction, 97(9), 1183–1194. https://doi.org/10.1046/j.1360-0443.2002.00185.x
  • Woolf-King, S. E., Sheinfil, A. Z., Ramos, J., Foley, J. D., Moskal, D., Firkey, M., Kellen, D., & Maisto, S. A. (2020). A conceptual model of alcohol use and adherence to antiretroviral therapy: systematic review and theoretical implications for mechanisms of action. Systematic Review and Theoretical Implications for Mechanisms of Action. Health Psychology Review, 104–133. https://doi.org/10.1080/17437199.2020.1806722
  • Yager, J., Faragon, J., McGuey, L., Hoye-Simek, A., Hecox, Z., Sullivan, S., Neubert, S., & Patel, N. (2017). Relationship between single tablet antiretroviral regimen and adherence to antiretroviral and non-antiretroviral medications among veterans’ affairs patients with human immunodeficiency virus. AIDS Patient Care and STDs, 31(9), 370–376. https://doi.org/10.1089/apc.2017.0081
  • Zhang, Y., Wilson, T. E., Adedimeji, A., Merenstein, D., Milam, J., Cohen, J., Cohen, M., & Golub, E. T. (2018). The impact of substance use on adherence to antiretroviral therapy among HIV-infected women in the United States. AIDS and Behavior, 22(3), 896–908. https://doi.org/10.1007/s10461-017-1808-4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.